SE392470B - Sett att framstella halvsyntetiska 1-substituerade derivat av kanamycin a eller b - Google Patents

Sett att framstella halvsyntetiska 1-substituerade derivat av kanamycin a eller b

Info

Publication number
SE392470B
SE392470B SE7209211A SE921172A SE392470B SE 392470 B SE392470 B SE 392470B SE 7209211 A SE7209211 A SE 7209211A SE 921172 A SE921172 A SE 921172A SE 392470 B SE392470 B SE 392470B
Authority
SE
Sweden
Prior art keywords
canamycin
synthetic
substituted derivatives
preparing semi
semi
Prior art date
Application number
SE7209211A
Other languages
English (en)
Swedish (sv)
Inventor
H Kawaguchi
T Naito
S Nakagawa
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE392470B publication Critical patent/SE392470B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7209211A 1971-07-13 1972-07-12 Sett att framstella halvsyntetiska 1-substituerade derivat av kanamycin a eller b SE392470B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16231571A 1971-07-13 1971-07-13
US22137872A 1972-01-27 1972-01-27

Publications (1)

Publication Number Publication Date
SE392470B true SE392470B (sv) 1977-03-28

Family

ID=26858650

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7209211A SE392470B (sv) 1971-07-13 1972-07-12 Sett att framstella halvsyntetiska 1-substituerade derivat av kanamycin a eller b

Country Status (24)

Country Link
JP (1) JPS5239024B2 (es)
AR (1) AR201265A1 (es)
AU (1) AU462657B2 (es)
BE (1) BE786201A (es)
CA (1) CA966831A (es)
CH (1) CH577502A5 (es)
CY (1) CY953A (es)
DD (1) DD98927A5 (es)
DK (1) DK136251B (es)
EG (1) EG10889A (es)
ES (1) ES404747A1 (es)
FI (1) FI56388C (es)
FR (1) FR2145649B1 (es)
GB (1) GB1401221A (es)
HK (1) HK33678A (es)
IE (1) IE36539B1 (es)
IL (1) IL39872A (es)
KE (1) KE2850A (es)
MY (1) MY7800312A (es)
NL (1) NL160271C (es)
PH (2) PH9589A (es)
SE (1) SE392470B (es)
SG (1) SG20778G (es)
YU (1) YU36533B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154536A (en) * 1974-11-06 1976-05-13 Banyu Pharma Co Ltd 6**nn * benjiruokishikaruboniru * kanamaishinjudotaino seiho
FR2318648A1 (fr) * 1975-07-23 1977-02-18 Roussel Uclaf Nouveau derive de la desoxystreptamine et des sels, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
SG20778G (en) 1987-04-03
AU462657B2 (en) 1975-07-03
PH9589A (en) 1976-01-19
CY953A (en) 1978-12-22
AR201265A1 (es) 1975-02-28
FI56388C (fi) 1980-01-10
CA966831A (en) 1975-04-29
EG10889A (en) 1976-10-31
FR2145649A1 (es) 1973-02-23
YU181872A (en) 1982-02-25
KE2850A (en) 1978-08-04
DK136251B (da) 1977-09-12
DD98927A5 (es) 1973-07-12
IE36539L (en) 1973-01-13
NL7209617A (es) 1973-01-16
IL39872A (en) 1974-10-22
IL39872A0 (en) 1972-09-28
IE36539B1 (en) 1976-11-24
FR2145649B1 (es) 1976-04-16
FI56388B (fi) 1979-09-28
JPS5239024B2 (es) 1977-10-03
NL160271C (nl) 1979-10-15
MY7800312A (en) 1978-12-31
AU4434372A (en) 1974-01-10
DE2234315B2 (de) 1977-03-17
GB1401221A (en) 1975-07-16
HK33678A (en) 1978-07-07
ES404747A1 (es) 1976-04-16
YU36533B (en) 1984-02-29
DK136251C (es) 1978-02-13
NL160271B (nl) 1979-05-15
CH577502A5 (es) 1976-07-15
BE786201A (fr) 1973-01-12
PH11440A (en) 1978-02-01
DE2234315A1 (de) 1973-02-08
JPS4834856A (es) 1973-05-22

Similar Documents

Publication Publication Date Title
SE381467B (sv) Forfarande for framstellning av azolderivat
CA994531A (en) Method of preparing ceramic structures
CA971954A (en) Method of preparing novel pyridine derivatives
SE403376B (sv) Sett att framstella derivat av 5-cinnamoylbensofuran
CA941251A (en) Vapour-liquid equilibrium still
SE435513B (sv) Forfarande for framstellning av derivat av kanamycin a eller b
CA978959A (en) (5-nitro-2-furyl)-pyridine compounds
SE7509126L (sv) Sett att framstella 1-substituerade 2-metyl-tetrahydropyrimidiner.
SE417711B (sv) Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat
ZA726627B (en) Method for the preparation of an over-glaze ceramic decalcomania
SE392470B (sv) Sett att framstella halvsyntetiska 1-substituerade derivat av kanamycin a eller b
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
SE409858B (sv) Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat
SE417972B (sv) Forfarande for framstellning av antibiotiska derivat av kanamycin a eller b
SE387119B (sv) Sett att framstella derivat av 6-gamma-dialkylaminoalkoxi-4,7-dimetoxibensofuraner
SE401832B (sv) Forfarande for framstellning av derivat av 2-formyl-3-karbonamido-kinoxalin-di-n-oxider
SE405118B (sv) Sett att framstella 2,4-diamino-5-bensylpyrimidiner
SE7605364L (sv) Forfarande for framstellning av antracenderivat
AU465345B2 (en) Helicopter vibration isolation
NO146986C (no) Fremgangsmaate for fremstilling av penicilliner eller cefalosporiner
CA983503A (en) Method of preparing 4-substituted-1-(4-ar1-4-ar2-butyl)-piperidines
SE393601B (sv) Forfarande for framstellning av 1-(acylamino-aryloxi)-3-aminopropanol-derivat utgaende fran tertiera azetidinolderivat
CS188900B2 (en) Method of producing semisynthetic derivatives of 1-substituted kanamycin a or b
CA864221A (en) Differential temperature well logging apparatus
CA877102A (en) Method of inhibiting lost circulation from a wellbore